Why NanoVibronix Shares Are Trading Higher By 49%; Here Are 20 Stocks Moving Premarket

Gainers

• AgileThought, Inc. AGIL rose 96.5% to $0.3046 in pre-market trading after falling 17% on Tuesday.
• Digital Brands Group, Inc. DBGI shares gained 57.9% to $13.33 in pre-market trading. DBGI effected a 1-for-25 reverse stock split on Tuesday.
• NanoVibronix, Inc. NAOV shares climbed 49% to $2.18 in pre-market trading after the company reported outcomes from a UroShield study conducted at the University of Southampton in the U.K.
• Tingo Group, Inc. TIO shares rose 42.4% to $1.21 in pre-market trading. Tingo Group announced completion of investigation into allegations made against the company in short-seller report and issued its response.
• Top KingWin Ltd. TCJH shares gained 30.5% to $1.7093 in pre-market trading after gaining 8% on Tuesday.
• Aravive, Inc. ARAV shares rose 24.4% to $0.1489 in pre-market trading after gaining over 6% on Tuesday.
• 1847 Holdings LLC EFSH gained 18.3% to $0.1150 in pre-market trading after the company announced plans to acquire a premier consumer products company with revenue in excess of $20 million and positive EBITDA in 2022.
• Dermata Therapeutics, Inc. DRMA shares jumped 17.6% to $1.20 in pre-market trading after falling 7% on Tuesday.
• Arcadia Biosciences, Inc. RKDA shares surged 14.3% to $4.00 in pre-market trading.
• Globalstar, Inc. GSAT rose 13% to $1.4799 in pre-market trading. Globalstar shares gained over 23% on Tuesday after the company announced it appointed Dr. Paul Jacobs as CEO and announced an agreement to license XCOM Labs technology.

Losers

• Outlook Therapeutics, Inc. OTLK fell 78.4% to $0.3050 in pre-market trading after the company received an FDA complete response letter regarding ONS-5010, an investigational ophthalmic formulation of bevacizumab under development to treat Wet Age-Related Macular Degeneration (Wet AMD).
• FibroGen, Inc. FGEN shares fell 24.2% to $0.9699 in pre-market trading after the company reported topline results from LELANTOS-2, a Phase 3 clinical study of pamrevlumab in ambulatory duchenne muscular dystrophy.
• MasterCraft Boat Holdings, Inc. MCFT fell 22.5% to $19.34 in pre-market trading after posting fourth-quarter results.
• Ambarella, Inc. AMBA fell 19.7% to $60.75 in pre-market trading after the company issued third-quarter revenue guidance below estimates.
• Genius Group Limited GNS shares fell 17.7% to $1.39 in pre-market trading after declining over 26% on Tuesday.
• TD Holdings, Inc. GLG fell 14.4% to $0.2534 in pre-market trading after dipping 72% on Tuesday.
• Tivic Health Systems, Inc. TIVC shares fell 12.7% to $2.60 in pre-market trading after jumping over 53% on Tuesday.
• VAALCO Energy, Inc. EGY fell 12.4% to $4.10 in pre-market.
• LENSAR, Inc. LNSR fell 11.7% to $3.09 in pre-market trading.
• OKYO Pharma Limited OKYO fell 7% to $2.84 in pre-market trading. OKYO Pharma achieved 90% enrollment in 240-patient Phase 2 clinical trial of OK-101 to treat dry eye disease.

Now Read This: Top 5 Consumer Stocks That May Rocket Higher This Quarter